Marta Tavares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marta Tavares has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Ana Isabel Lopes
Gastroenterology Unit, Paediatrics Department, FMUL -Medical Faculty, University of Lisbon, Unidade Local de Saude Santa Maria, Lisbon, Portugal
2 shared publications- Rosa Lima
Gastroenterology Unit, Pediatrics Department, Centro Materno‐Infantil do Norte Albino Aroso Unidade Local de Saúde Santo António Porto Portugal
2 shared publications Alexandru Pirvan
Gastroenterology Unit Paediatric Department number 2 Emergency Clinical Hospital for Children Cluj Napoca Romania
1 shared publicationAmit Assa
The Pediatric Gastroenterology Unit, Kaplan Medical Center, Rehovot, The Hebrew University Jerusalem Israel
1 shared publication- Ana Lachado
Hematology Unit, Pediatrics Department, Centro Materno‐Infantil do Norte Albino Aroso Unidade Local de Saúde Santo António Porto Portugal
1 shared publication Anatoly Kavkin
Moscow Regional Center for Paediatric Gastroenterology and Hepatology named after A.V. Mazurin Research Clinical Institute of Childhood Moscow The Russian Federation
1 shared publication
Latest Publications
- 19 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 860
Paediatric Helicobacter pylori infection and allergic and inflammatory diseases: a contemporary systematic review with meta-analysis
- 19 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 860
Paediatric Helicobacter pylori infection and allergic and inflammatory diseases: a contemporary systematic review with meta-analysis
- 7 September 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Therapeutic response to ferric hydroxide versus ferrous glycine sulfate in pediatric autoimmune gastritis–related iron deficiency anemia
Objectives: Autoimmune gastritis (AIG) is characterized by immune‐mediated destruction of gastric parietal cells and impaired iron absorption. Refractory iron deficiency anemia (IDA) is often the main clinical presentation in pediatric patients. Because oral ferrous glycine sulfate (FGS) is absorbed independently of gastric pH, it may represent an effective alternative to ferric hydroxide (FH) in this setting. Aim: To compare the therapeutic response to FH and FGS in children and adolescents with AIG‐associated IDA. Methods: We conducted a retrospective observational cohort study including pediatric patients diagnosed with AIG‐associated IDA and followed at a tertiary Pediatric Gastroenterology Unit between 2007 and 2023. Treatment non‐response was defined as a hemoglobin (Hb) increase p < 0.001), with normalization of Hb and ferritin achieved in 86% and 81% of patients, respectively. Two patients treated initially with FGS also demonstrated favorable hematologic responses. Conclusions: In this retrospective cohort, FGS was associated with substantial hematologic improvement in pediatric patients with AIG‐associated IDA, particularly in those who had failed previous FH therapy.
- 7 September 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Therapeutic response to ferric hydroxide versus ferrous glycine sulfate in pediatric autoimmune gastritis–related iron deficiency anemia
Objectives: Autoimmune gastritis (AIG) is characterized by immune‐mediated destruction of gastric parietal cells and impaired iron absorption. Refractory iron deficiency anemia (IDA) is often the main clinical presentation in pediatric patients. Because oral ferrous glycine sulfate (FGS) is absorbed independently of gastric pH, it may represent an effective alternative to ferric hydroxide (FH) in this setting. Aim: To compare the therapeutic response to FH and FGS in children and adolescents with AIG‐associated IDA. Methods: We conducted a retrospective observational cohort study including pediatric patients diagnosed with AIG‐associated IDA and followed at a tertiary Pediatric Gastroenterology Unit between 2007 and 2023. Treatment non‐response was defined as a hemoglobin (Hb) increase p < 0.001), with normalization of Hb and ferritin achieved in 86% and 81% of patients, respectively. Two patients treated initially with FGS also demonstrated favorable hematologic responses. Conclusions: In this retrospective cohort, FGS was associated with substantial hematologic improvement in pediatric patients with AIG‐associated IDA, particularly in those who had failed previous FH therapy.
- 31 July 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (4) , 665-674
Assessment of professional practise on Helicobacter pylori in paediatrics: A pan‐European study
Objectives: Recent guidelines provide insightful information on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection. The knowledge of the latest guidelines for European paediatric gastroenterologists is currently being discussed. This study aimed to evaluate the current knowledge regarding paediatric H. pylori management. Methods: Members from the National Societies of the European Society of Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) were invited to complete an online questionnaire. Descriptive and statistical analyses were conducted using SPSS®. Results: A questionnaire was completed by 508 paediatric healthcare professionals from 32 countries (60% were specialists, 82% worked in hospitals and 49% in university hospitals). Of these, 360 (71%) had a background in paediatric gastroenterology. In 30% of cases, the local prevalence of H. pylori was unknown. Primary testing indications included duodenal or gastric erosions (85%), oral iron‐refractory anaemia (59%) and a positive family history of gastric cancer (41%), 7.5% complied with the guidelines. Fifty‐seven per cent requested invasive diagnostic tests, including culture (66%) and molecular tests (34%). The test‐and‐treat strategy was considered by 43% of clinicians, and more than half of respondents would include probiotics in eradication. Amoxicillin‐based therapies represented 77% of prescriptions, with 54% opting for clarithromycin for empirical treatment. Additionally, the eradication regimens varied significantly across different European regions, with limited/small differences by clinician category. Conclusions: This study among healthcare professionals revealed that H. pylori infection management does not entirely follow the guidelines regarding indications, testing and treatment regimens. There is a need for education in Europe to increase literacy and clinical updates.
- 31 July 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (4) , 665-674
Assessment of professional practise on Helicobacter pylori in paediatrics: A pan‐European study
Objectives: Recent guidelines provide insightful information on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection. The knowledge of the latest guidelines for European paediatric gastroenterologists is currently being discussed. This study aimed to evaluate the current knowledge regarding paediatric H. pylori management. Methods: Members from the National Societies of the European Society of Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) were invited to complete an online questionnaire. Descriptive and statistical analyses were conducted using SPSS®. Results: A questionnaire was completed by 508 paediatric healthcare professionals from 32 countries (60% were specialists, 82% worked in hospitals and 49% in university hospitals). Of these, 360 (71%) had a background in paediatric gastroenterology. In 30% of cases, the local prevalence of H. pylori was unknown. Primary testing indications included duodenal or gastric erosions (85%), oral iron‐refractory anaemia (59%) and a positive family history of gastric cancer (41%), 7.5% complied with the guidelines. Fifty‐seven per cent requested invasive diagnostic tests, including culture (66%) and molecular tests (34%). The test‐and‐treat strategy was considered by 43% of clinicians, and more than half of respondents would include probiotics in eradication. Amoxicillin‐based therapies represented 77% of prescriptions, with 54% opting for clarithromycin for empirical treatment. Additionally, the eradication regimens varied significantly across different European regions, with limited/small differences by clinician category. Conclusions: This study among healthcare professionals revealed that H. pylori infection management does not entirely follow the guidelines regarding indications, testing and treatment regimens. There is a need for education in Europe to increase literacy and clinical updates.
- 4 August 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (9) , 1092-1094
Metastatic Crohn's disease in paediatrics: Vulvar lesions as the first clinical presentation
- 4 August 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (9) , 1092-1094
Metastatic Crohn's disease in paediatrics: Vulvar lesions as the first clinical presentation
- Open Access
- 31 August 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (9) , 632-633
The Stool Color Card as a Screening Tool for Biliary Atresia in the Digital Version of the Portuguese Child and Youth Health Booklet
The Stool Color Card as a Screening Tool for Biliary Atresia in the Digital Version of the Portuguese Child and Youth Health Booklet
- 31 August 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (9) , 632-633
Open AccessThe Stool Color Card as a Screening Tool for Biliary Atresia in the Digital Version of the Portuguese Child and Youth Health Booklet
The Stool Color Card as a Screening Tool for Biliary Atresia in the Digital Version of the Portuguese Child and Youth Health Booklet